Chicagoland Peptides products are Research Use Only ("RUO") and are intended solely for basic research, pharmaceutical research, laboratory experimentation, or the development of new tests — not for diagnosing, treating, curing, or preventing any disease or condition in any patient. These statements have not been evaluated by the U.S. Food and Drug Administration.
Learn
Start here
Fundamentals
Lyophilized Peptide and Protein Cold Chain Stability: What the Published Literature Reports
A research-framing review of published studies on how freeze-drying, excipient selection, and storage temperature affect the physical and functional stability of peptide, protein, and peptide-loaded particulate formulations, with each finding labelled by the model in which it was studied.
Last reviewed: September 16, 2026
Peptide Identity by Mass Spectrometry Fragmentation: What the Published Literature Reports
A research-library overview of how the published methodological literature approaches peptide identity confirmation by tandem mass spectrometry: bottom-up versus top-down fragmentation, collisional activation physics, targeted transition selection, de novo and paired-digestion strategies, modification and glycopeptide site assignment, and documented software misassignment pitfalls. Findings are reported with the model in which each was studied.
Last reviewed: September 16, 2026
Benzyl Alcohol Preserved Diluent and Peptide Stability: What the Published Record Shows
A research-framing overview of the published laboratory evidence on reconstituting or diluting a protein solution with bacteriostatic (benzyl alcohol preserved) sodium chloride, drawn from a single analytical stability and preservative-effectiveness study of epoetin alfa dilutions.
Last reviewed: September 17, 2026
Reconstituted Peptide Stability and Temperature: What the Published Literature Reports
A research-framed survey of published studies on how storage temperature, lyophilisation, excipients, and handling stress affect peptides and related biomolecules after reconstitution, with each finding labelled by the model in which it was observed.
Last reviewed: September 16, 2026
Residual Moisture and the Stability of Lyophilized Peptides and Proteins: What the Literature Reports
A research-library review of published freeze-drying studies examining how residual moisture content in lyophilized peptide and protein cakes relates to chemical degradation, aggregation, glass transition behaviour, and measured storage stability. Findings are laboratory (in vitro) unless otherwise noted; one cited study included an animal biodistribution comparison.
Last reviewed: September 17, 2026
Lab reports & purity
Peptide Certificates of Analysis: What the HPLC and Mass Spectrometry Literature Reports
A research-framed overview of how published analytical chemistry studies use HPLC, LC-MS/MS, and isotope dilution mass spectrometry to certify peptide purity, content, identity, and stability — and what each method was validated in.
Last reviewed: September 16, 2026
HPLC in Peptide Purity Analysis: What the Published Literature Reports
A research-framing review of how high-performance liquid chromatography and its hyphenated variants have been used in published studies to characterise synthetic peptide purity, chiral purity, impurity profiles, and radiochemical purity, with notes on reported limitations and orthogonal methods.
Last reviewed: September 16, 2026
LC-MS and Peptide Purity: What the Analytical Literature Reports
A research-framing overview of how published analytical studies use liquid chromatography–mass spectrometry to confirm peptide identity, separate co-eluting impurities, and assign purity values, including isotope dilution, qNMR-orthogonal, and multi-attribute method approaches. All findings described are from analytical and preclinical work.
Last reviewed: September 16, 2026
Certificates of Analysis, Peptide Purity, and the Role of HPLC in the Published Literature
A research-framing overview of what published analytical studies report about high-performance liquid chromatography as a purity and content method for peptides and proteins, including certified reference material work on amyloid-beta and reversed-phase separation of insulin and related substances.
Last reviewed: September 16, 2026
Gradient Versus Isocratic Elution in Reversed-Phase HPLC Purity Chromatograms: What One Peptide Isolation Study Reported
A research-framing overview of a single published reversed-phase HPLC study of recombinant human IGF-1, in which shallow gradient elution, mobile-phase pH, ionic strength, column temperature, and particle characteristics were varied and the resulting chromatographic resolution, recovery, and reported purity were compared across analytical and preparative scales.
Last reviewed: September 17, 2026
Storage & handling
Storage & Handling
What published stability literature reports about lyophilised versus liquid peptides, temperature, light, and freeze–thaw, as studied in vitro.
Last reviewed: September 15, 2026
Lyophilized Peptide and Protein Stability: What Storage Studies Report
A research-framed review of published findings on how lyophilization, formulation excipients, residual moisture, glass transition temperature, and storage temperature relate to chemical and physical degradation of peptides and proteins in the solid state, with each finding labelled by the model in which it was studied.
Last reviewed: September 16, 2026
BPC-157
BPC-157
What published studies reported for BPC-157, labelled by model: in vitro, animal, or human tissue.
Last reviewed: September 15, 2026
BPC-157 in Cell-Based Endothelial Models: What the In Vitro Literature Reports
A research-library summary of the published in vitro work on BPC-157 in endothelial cell culture, including proliferation, migration, tube formation and ERK1/2-associated signalling readouts, with notes on the accompanying rodent model and on the absence of fibroblast-specific data in the retrieved set.
Last reviewed: September 16, 2026
BPC-157 in Vitro: What Cell-Based and Isolated-Tissue Studies Report
A research-library review of published in vitro work on the pentadecapeptide BPC-157, covering fibroblast and endothelial cell assays, HEK293 membrane-potential experiments, hepatocyte culture models, and in vitro metabolism studies, with the model system stated for each finding.
Last reviewed: September 16, 2026
Semaglutide
Semaglutide and the GLP-1 Receptor: What the Published Research Reports
A research-framed overview of the published literature on semaglutide, covering its molecular design and GLP-1 receptor affinity in preclinical characterisation work, mechanistic hypotheses from preclinical and clinical reviews, and reported outcomes in human trials, cohort studies, and pharmacovigilance datasets.
Last reviewed: September 16, 2026
Semaglutide and the GLP-1 Receptor: What Binding and Receptor-Engagement Assays Report
A research-library survey of published structural, radioligand competition, cell-based signalling, and albumin-binding assay work in which semaglutide was characterised or used as a comparator at the GLP-1 receptor, with the model system (in vitro, animal, or human) stated for each finding.
Last reviewed: September 16, 2026
Semaglutide: What the Published Studies Report
A research-framed survey of the published semaglutide literature, covering head-to-head human trials in type 2 diabetes and obesity, combination and real-world cohort data, reported adverse-event patterns, and preclinical rodent work on alcohol-related behaviour.
Last reviewed: September 16, 2026
Tirzepatide
Tirzepatide as a Dual GIP/GLP-1 Receptor Agonist: What the Published Research Reports
A research-framed overview of published in vitro, animal, and human studies on tirzepatide, a single peptide engineered to engage both the GIP and GLP-1 receptors, covering receptor pharmacology, reported metabolic endpoints in clinical trials, preclinical mechanistic work, and documented tolerability observations.
Last reviewed: September 16, 2026
Tirzepatide Pharmacokinetics in Animal Models: What the Published Literature Reports
A research-framed summary of published findings on tirzepatide disposition in rats, including a validated LC-MS/MS bioanalytical method, reported terminal half-lives after intravenous and subcutaneous administration, and estimated subcutaneous bioavailability, alongside a scoping review mapping preclinical and clinical evidence for this dual GIP/GLP-1 receptor agonist.
Last reviewed: September 16, 2026
Tirzepatide: A Research Overview
A research-framed summary of what published reviews, systematic reviews and meta-analyses report about tirzepatide, a dual GIP and GLP-1 receptor agonist, across glycaemic, body-weight, cardiorenal, hepatic and adverse-event endpoints, with each finding labelled by the model in which it was studied.
Last reviewed: September 16, 2026
CJC-1295
CJC-1295 and Ipamorelin in Animal Growth Hormone Research: What the Published Literature Reports
A research-framing overview of how CJC-1295 and ipamorelin appear in the peer-reviewed musculoskeletal literature, drawing on a PRISMA-guided scoping review that found the evidence base is dominated by preclinical animal models, with human investigations limited and methodologically heterogeneous.
Last reviewed: September 16, 2026
CJC-1295 and Ipamorelin in the GH–IGF-1 Axis Literature: What Published Reviews Report
A research-framing overview of how two 2026 narrative reviews characterise CJC-1295 (with and without DAC) and ipamorelin within the growth hormone–IGF-1 axis literature, including how the reviews classify the strength of human evidence, reported adverse-effect domains, product-quality uncertainty, and antidoping context.
Last reviewed: September 16, 2026
Ipamorelin
CJC-1295 and Ipamorelin in Animal Growth Hormone Research: What the Published Literature Reports
A research-framing overview of how CJC-1295 and ipamorelin appear in the peer-reviewed musculoskeletal literature, drawing on a PRISMA-guided scoping review that found the evidence base is dominated by preclinical animal models, with human investigations limited and methodologically heterogeneous.
Last reviewed: September 16, 2026
CJC-1295 and Ipamorelin in the GH–IGF-1 Axis Literature: What Published Reviews Report
A research-framing overview of how two 2026 narrative reviews characterise CJC-1295 (with and without DAC) and ipamorelin within the growth hormone–IGF-1 axis literature, including how the reviews classify the strength of human evidence, reported adverse-effect domains, product-quality uncertainty, and antidoping context.
Last reviewed: September 16, 2026
Ipamorelin and the Ghrelin/GHSR System: What the Published Literature Covers
A research-library summary of the available cited literature linking ipamorelin to the ghrelin/growth hormone secretagogue receptor (GHSR) axis, drawn from a teleost study in black seabream that characterised the ghrelin gene and examined ghrelin transcript levels after in vivo ipamorelin administration.
Last reviewed: September 16, 2026
Tesamorelin
PT-141
PT-141 (Bremelanotide) and Melanocortin Receptor Signalling: A Research Overview
A citation-indexed survey of the published literature on PT-141 (bremelanotide), a synthetic alpha-MSH analogue characterised as an agonist at melanocortin receptors MC3R and MC4R, covering receptor pharmacology, preclinical models, and the human trial record.
Last reviewed: September 16, 2026
PT-141 (Bremelanotide): What the Published Research Reports
A citation-indexed overview of the published literature on PT-141 (bremelanotide), a cyclic melanocortin receptor agonist peptide, covering receptor structural work in vitro, rodent and hamster mechanistic models, randomized human trials in sexual dysfunction populations, reported adverse-event profiles, and analytical and delivery studies.
Last reviewed: September 16, 2026
Selank
Selank: A Research Guide to the Published Literature
A citation-by-citation overview of published Selank research, covering receptor-level and cell-culture work, rodent behavioural and gene-expression studies, and the small human imaging and clinical literature, with the model system stated for each finding.
Last reviewed: September 16, 2026
Selank as a Tuftsin Analogue: What Animal Studies Report
A research summary of the retrieved animal literature on Selank, a synthetic heptapeptide analogue of the immunopeptide tuftsin, covering inflammation-related gene expression changes in mouse spleen and behavioural and serotonin-metabolism observations in rats.
Last reviewed: September 16, 2026
NAD+
NAD+ and Cellular Redox Metabolism: What the Published Research Reports
A research-framed overview of published in vitro, animal, and human studies on the NAD+/NADH redox couple, its subcellular compartmentation, the genetically encoded tools used to measure and manipulate it, and the metabolic states reported when that ratio shifts.
Last reviewed: September 16, 2026
Measuring NAD+ by HPLC and Mass Spectrometry: What the Analytical Literature Reports
A research-framing overview of published HPLC and LC-MS/MS methods used to quantify NAD+ and related pyridine nucleotides, covering HILIC and ion-pairing reversed-phase separations, isotope-dilution internal standards, reported detection limits and validation parameters, and the biological matrices — microbial, cell-culture, animal, and human — in which each method was tested.
Last reviewed: September 16, 2026
NAD+ and Mitochondrial Metabolism: What the Research Literature Reports
A research-framed overview of published work on NAD+ in mitochondrial metabolism, covering the identification of the mitochondrial NAD+ transporter SLC25A51 in cell systems, compartment-specific NAD+/NADH measurement and manipulation tools, sirtuin-linked findings in rodent and invertebrate models, and observational metabolic data from human tissues. Each finding is labelled by the model in which it was studied.
Last reviewed: September 17, 2026
Kisspeptin
Kisspeptin-10 Analogue Receptor Pharmacology: A Research Literature Review
A citation-indexed survey of published in vitro, animal, and human studies characterising how kisspeptin-10 (KP-10) and its structural analogues engage KISS1R, including structure-activity mapping, signalling readouts, desensitisation behaviour, antagonist design, radiolabelled conjugates, and off-target receptor activation.
Last reviewed: September 16, 2026
Kisspeptin and the KISS1R/GPR54 Receptor: What Animal and Cell Signalling Studies Report
A research-library overview of published findings on kisspeptin signalling through its G protein-coupled receptor KISS1R (GPR54), covering GnRH neuron electrophysiology in rodents, non-neuronal receptor expression, intracellular signalling and desensitisation, and reported findings in peripheral tissue models. Each finding is labelled by the model in which it was studied.
Last reviewed: September 16, 2026
SS-31
Elamipretide (SS-31): What the Published Mitochondrial Research Reports
A research-library overview of elamipretide (SS-31), a synthetic mitochondria-targeting tetrapeptide described as binding cardiolipin in the inner mitochondrial membrane [1]. The literature summarised here is largely in vitro and animal work spanning cardiac, skeletal muscle, neural, renal, pulmonary and ocular models [3][5][6][10][15][16][17][18], alongside narrative reviews that note clinical trials have been conducted and that rigorous human data for non-approved peptide use remain limited [1][20].
Last reviewed: September 16, 2026
SS-31 (Elamipretide): What the Published Research Reports
A research-library overview of SS-31 (elamipretide), a mitochondria-targeted tetrapeptide, summarising what cell-based, animal, and review literature reports about its cardiolipin interaction, bioenergetic effects, and organ-specific preclinical models.
Last reviewed: September 16, 2026
SS-31 (Elamipretide) Animal Study Design: Models, Controls, and Endpoints in the Published Literature
A research-framing overview of how published preclinical studies of SS-31 (elamipretide) were designed — the animal models used, comparator arms, treatment windows, and mitochondrial and functional endpoints measured — alongside the in vitro work that informs those designs.
Last reviewed: September 16, 2026
Semax
Epithalon
Epithalon (Epitalon) and Telomere Research: What the Published Cell Studies Report
Epithalon (Ala-Glu-Asp-Gly) has been studied in cultured human fetal fibroblasts, where investigators reported induction of telomerase catalytic subunit expression, telomerase activity, telomere elongation, and additional population doublings past the point at which control cultures stopped dividing [1][2]. Both reports are in vitro; no human outcome data are included in this reference set.
Last reviewed: September 16, 2026
Epithalon (Epitalon, AEDG): Research Overview
A research-framing overview of the pineal tetrapeptide Epithalon (Epitalon, AEDG; Ala-Glu-Asp-Gly), drawing on a 2025 review that summarises roughly 25 years of in vitro, in vivo, and in silico investigation into its reported neuroendocrine, antioxidant, antimutagenic, and enzyme-modulating activities, and notes the limited physico-chemical and structural literature.
Last reviewed: September 16, 2026
Thymosin Alpha-1
Thymosin Alpha-1 in Immune Model Research: What the Published Studies Report
A research-library overview of published in vitro, animal, and clinical-cohort studies examining thymosin alpha-1 (Tα1) in immune models, including tumour-bearing mice, sepsis and pancreatitis models, dendritic cell and macrophage assays, human lymphocyte cultures, and membrane-interaction work.
Last reviewed: September 16, 2026
Thymosin Alpha-1: What the Published Research Reports
A research-library overview of published thymosin alpha-1 (Tα1) literature, covering endogenous measurement, in vitro thymocyte and killer-cell work, and clinical investigations in hepatitis B, sepsis, pancreatitis, COVID-19 and oncology — with the model system stated for each finding.
Last reviewed: September 16, 2026
GHK-Cu
GHK-Cu Copper Peptide: What the Published Research Reports
A research-library overview of the published literature on the tripeptide GHK and its copper(II) complex GHK-Cu, covering coordination chemistry, cell-culture work, animal and invertebrate models, biomaterial delivery systems, and the limits of current human data.
Last reviewed: September 16, 2026
GHK-Cu, Copper Binding, and Extracellular Matrix Remodelling: What the Published Studies Report
A research-library summary of two published studies examining GHK-Cu as a copper source in a Golgi-targeted delivery system evaluated in vitro and in a rabbit fascia defect model, and biotinylated GHK incorporated into a collagen matrix evaluated in rats.
Last reviewed: September 16, 2026
DSIP
DSIP (Delta Sleep-Inducing Peptide) in Animal Models: A Research Literature Overview
A citation-indexed survey of published preclinical work on delta sleep-inducing peptide (DSIP), covering its isolation from rabbit cerebral venous blood, species-divergent EEG and sleep findings in rabbits, rats and cats, neuroendocrine and thermoregulatory observations in rats, barrier-transport studies in dogs, sheep and neonatal rats, and immunohistochemical mapping across vertebrates. Preclinical only; no human outcomes are asserted.
Last reviewed: September 16, 2026
DSIP (Delta Sleep-Inducing Peptide): What the Published Literature Reports
A research-literature overview of delta sleep-inducing peptide (DSIP), covering its isolation in rabbit studies, structure–activity work in rats, controlled human sleep laboratory trials, immunoreactivity measurements in clinical populations, and in vitro conformational and phosphorylation studies.
Last reviewed: September 16, 2026
Retatrutide
AOD-9604
Melanotan II
Melanotan II and Melanocortin Receptor Signalling in Animal Models: A Research Summary
A citation-indexed overview of published preclinical work on melanotan II (MT-II), a non-selective melanocortin receptor agonist, covering receptor pharmacology, feeding and energy expenditure, ethanol intake, stress and social behaviour models, erectile and proceptive behaviour, and peripheral nerve studies in rodents.
Last reviewed: September 16, 2026
Melanotan II in Melanocortin Receptor Pharmacology: A Research Literature Overview
A research-framed survey of published in vitro, animal, and clinical-development literature on Melanotan II (MT-II), a cyclic non-selective melanocortin receptor agonist, covering receptor affinity and selectivity studies, brain penetration and pharmacokinetic measurements, and the feeding, neuroendocrine, behavioural, and metabolic endpoints reported in rodent, avian, and fish models.
Last reviewed: September 17, 2026
Glutathione
Glutathione as an Antioxidant Peptide: What the Published Research Reports
A research-framed survey of the published literature on glutathione (GSH), the intracellular tripeptide, covering how its synthesis is regulated, how GSH pools are measured as a redox readout in cell and animal models, how peptides have been reported to modulate the glutathione system, and how GSH is used as a comparator in antioxidant peptide characterisation studies.
Last reviewed: September 16, 2026
Glutathione: A Research Overview of the Tripeptide and Its Redox Biology
A literature overview of glutathione (γ-glutamylcysteinylglycine), the tripeptide thiol described in published reviews of cellular redox biochemistry, conjugation and detoxification chemistry, plant and mammalian cell models, and glutathione-responsive chemistry used in preclinical drug-design research.
Last reviewed: September 16, 2026